Literature DB >> 7543433

The virological and histological states of anti-hepatitis C virus-positive subjects with normal liver biochemical values.

M Shindo1, K Arai, Y Sokawa, T Okuno.   

Abstract

We investigated anti-hepatitis C virus (HCV) titers, HCV RNA levels in liver and serum, genetic variability in the hypervariable region of the genome, the form of the virus in the circulation, and liver histology in 21 anti-HCV-positive subjects with sustained normal liver biochemical values. Titer of anti-HCV was determined by second generation anti-HCV-passive hemagglutination assay, and HCV RNA levels were semiquantitated by reverse transcriptase polymerase chain reaction (PCR). In 19 (90%) of the 21 subjects who had a higher titer of anti-HCV (> or = 2(14)), HCV RNA was detected in both serum and liver, and histological examination showed minimal or mild chronic hepatitis in all. In the remaining 2 patients who had a lower titer of anti-HCV, HCV RNA was not detected in serum and liver, and liver histology was normal. Anti-HCV titers and HCV RNA levels in serum and liver in the 19 HCV RNA-positive subjects were compared with those levels in the 41 patients with biopsy-proven chronic hepatitis C and elevated serum aminotransferase levels as a control group. There were no significant differences in viral levels in serum and liver between the two groups. To further investigate virological differences between the two groups with regard to degree of genetic variability and the form in the circulation, we performed the PCR-single strand conformation polymorphism (PCR-SSCP) of the hypervariable region 1 and the immunoprecipitation analyses.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7543433

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  14 in total

1.  Assessment of liver histology in chronic alcoholics with and without hepatitis C virus infection.

Authors:  S Anderson; C L Nevins; L K Green; H El-Zimaity; B S Anand
Journal:  Dig Dis Sci       Date:  2001-07       Impact factor: 3.199

Review 2.  [Therapy of hepatitis C].

Authors:  D M Alscher; J C Bode
Journal:  Med Klin (Munich)       Date:  1997-03-15

3.  Occurrence of HCC in asymptomatic HCV-related chronic hepatitis.

Authors:  Marcello Persico; Bruno Palmentieri; Leonardo Coppola; Giovanni Di Giacomo Russo; Fedele De Marino; Ilario De Sio; Roberto Torella
Journal:  Dig Dis Sci       Date:  2002-11       Impact factor: 3.199

4.  Long-term efficacy of interferon-alpha and ursodeoxycholic acid in treatment of chronic type C hepatitis.

Authors:  H Senturk; O Uzunalimoglu; Y Batur; I Simsek; A Mert; G Ozbay; H Cetinkaya; G Ersoz; F Tabak; H Akbaylar; M Akdogan; A Dokmeci; A Sonsuz; S Ozenirler; E Erden; N Tozum
Journal:  Dig Dis Sci       Date:  1997-07       Impact factor: 3.199

5.  Pathomorphological Characteristics and Pathogenesis of Viral Hepatitis.

Authors:  Zsuzsa Schaff; Gábor Lotz; Rolf Schulte-Herman
Journal:  Pathol Oncol Res       Date:  1996       Impact factor: 3.201

6.  Correlation between serum HCV RNA and aminotransferase levels in patients with chronic HCV infection.

Authors:  M G Ghany; T M Chan; R Sanchez-Pescador; M Urdea; A S Lok
Journal:  Dig Dis Sci       Date:  1996-11       Impact factor: 3.199

7.  Histological features and HLA class II alleles in hepatitis C virus chronically infected patients with persistently normal alanine aminotransferase levels.

Authors:  C Renou; P Halfon; S Pol; P Cacoub; E Jouve; J P Bronowicki; J P Arpurt; H Rifflet; M Picon; X Causse; V Canva; J Denis; A Tran; M Bourliére; D Ouzan; A Pariente; S Dantin; L Alric; V Cartier; M Reville; S Caillat-Zucman
Journal:  Gut       Date:  2002-10       Impact factor: 23.059

8.  Plasma hydroxy metronidazole/metronidazole ratio in anti-HCV carriers with and without apparent liver disease.

Authors:  C M da Silva; F L David; M N Muscará; S S Sousa; J G Ferraz; G de Nucci; N C Polimeno; J Pedrazzoli
Journal:  Br J Clin Pharmacol       Date:  1998-08       Impact factor: 4.335

9.  Mother to child transmission of hepatitis C virus: prospective study of risk factors and timing of infection in children born to women seronegative for HIV-1. Tuscany Study Group on Hepatitis C Virus Infection.

Authors:  M Resti; C Azzari; F Mannelli; M Moriondo; E Novembre; M de Martino; A Vierucci
Journal:  BMJ       Date:  1998-08-15

10.  Outcomes of interferon alpha and ribavirin treatment for chronic hepatitis C in patients with normal serum aminotransaminases.

Authors:  C-K Hui; A Monto; T Belaye; E Lau; T L Wright
Journal:  Gut       Date:  2003-11       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.